136 related articles for article (PubMed ID: 37698384)
1. Pharmacological characterization of SAGE-718, a novel positive allosteric modulator of N-methyl-d-aspartate receptors.
Beckley JT; Aman TK; Ackley MA; Kazdoba TM; Lewis MC; Smith AC; Farley BJ; Dai J; Deats W; Hoffmann E; Robichaud AJ; Doherty JJ; Quirk MC
Br J Pharmacol; 2024 Apr; 181(7):1028-1050. PubMed ID: 37698384
[TBL] [Abstract][Full Text] [Related]
2. SAGE-718: A First-in-Class
Hill MD; Blanco MJ; Salituro FG; Bai Z; Beckley JT; Ackley MA; Dai J; Doherty JJ; Harrison BL; Hoffmann EC; Kazdoba TM; Lanzetta D; Lewis M; Quirk MC; Robichaud AJ
J Med Chem; 2022 Jul; 65(13):9063-9075. PubMed ID: 35785990
[No Abstract] [Full Text] [Related]
3. Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel.
Emnett CM; Eisenman LN; Mohan J; Taylor AA; Doherty JJ; Paul SM; Zorumski CF; Mennerick S
Br J Pharmacol; 2015 Mar; 172(5):1333-47. PubMed ID: 25377730
[TBL] [Abstract][Full Text] [Related]
4. PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits.
Yi F; Rouzbeh N; Hansen KB; Xu Y; Fanger CM; Gordon E; Paschetto K; Menniti FS; Volkmann RA
Neuropharmacology; 2020 Aug; 173():107971. PubMed ID: 31987864
[TBL] [Abstract][Full Text] [Related]
5. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors.
Paul SM; Doherty JJ; Robichaud AJ; Belfort GM; Chow BY; Hammond RS; Crawford DC; Linsenbardt AJ; Shu HJ; Izumi Y; Mennerick SJ; Zorumski CF
J Neurosci; 2013 Oct; 33(44):17290-300. PubMed ID: 24174662
[TBL] [Abstract][Full Text] [Related]
6. Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions.
Tang W; Beckley JT; Zhang J; Song R; Xu Y; Kim S; Quirk MC; Robichaud AJ; Diaz ES; Myers SJ; Doherty JJ; Ackley MA; Traynelis SF; Yuan H
Cell Mol Life Sci; 2023 Jan; 80(2):42. PubMed ID: 36645496
[TBL] [Abstract][Full Text] [Related]
7. The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca
Perszyk RE; Zheng Z; Banke TG; Zhang J; Xie L; McDaniel MJ; Katzman BM; Pelly SC; Yuan H; Liotta DC; Traynelis SF
Mol Pharmacol; 2021 May; 99(5):399-411. PubMed ID: 33688039
[TBL] [Abstract][Full Text] [Related]
8. Neuroactive Steroid
La DS; Salituro FG; Martinez Botella G; Griffin AM; Bai Z; Ackley MA; Dai J; Doherty JJ; Harrison BL; Hoffmann EC; Kazdoba TM; Lewis MC; Quirk MC; Robichaud AJ
J Med Chem; 2019 Aug; 62(16):7526-7542. PubMed ID: 31390523
[TBL] [Abstract][Full Text] [Related]
9. The role of the mGluR allosteric modulation in the NMDA-hypofunction model of schizophrenia.
Doreulee N; Alania M; Mitaishvili E; Chikovani M; Chkhartishvili B
Georgian Med News; 2009 Dec; (177):59-65. PubMed ID: 20090156
[TBL] [Abstract][Full Text] [Related]
10. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
Wilding TJ; Lopez MN; Huettner JE
J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
[TBL] [Abstract][Full Text] [Related]
11. Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.
Yi F; Bhattacharya S; Thompson CM; Traynelis SF; Hansen KB
J Physiol; 2019 Nov; 597(22):5495-5514. PubMed ID: 31541561
[TBL] [Abstract][Full Text] [Related]
12. A novel family of negative and positive allosteric modulators of NMDA receptors.
Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
[TBL] [Abstract][Full Text] [Related]
13. The mGlu₅ positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the rat.
Gastambide F; Gilmour G; Robbins TW; Tricklebank MD
Neuropharmacology; 2013 Jan; 64():240-7. PubMed ID: 22884612
[TBL] [Abstract][Full Text] [Related]
14. The positive allosteric modulator of NMDA receptors, GNE-9278, blocks the ethanol-induced decrease of excitability in developing retrosplenial cortex neurons from mice.
Bird CW; Valenzuela CF
Neuropsychopharmacol Rep; 2023 Mar; 43(1):77-84. PubMed ID: 36524248
[TBL] [Abstract][Full Text] [Related]
15. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
[No Abstract] [Full Text] [Related]
16. Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis.
Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E; García-Serra A; Maudes E; Pedreño M; Paul S; Doherty J; Quirk M; Dai J; Gasull X; Lewis M; Dalmau J
Brain; 2020 Sep; 143(9):2709-2720. PubMed ID: 32830245
[TBL] [Abstract][Full Text] [Related]
17. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
[No Abstract] [Full Text] [Related]
18. Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives.
Sapkota K; Irvine MW; Fang G; Burnell ES; Bannister N; Volianskis A; Culley GR; Dravid SM; Collingridge GL; Jane DE; Monaghan DT
Neuropharmacology; 2017 Oct; 125():64-79. PubMed ID: 28709671
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
Khatri A; Burger PB; Swanger SA; Hansen KB; Zimmerman S; Karakas E; Liotta DC; Furukawa H; Snyder JP; Traynelis SF
Mol Pharmacol; 2014 Nov; 86(5):548-60. PubMed ID: 25205677
[TBL] [Abstract][Full Text] [Related]
20. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
Gilling KE; Jatzke C; Hechenberger M; Parsons CG
Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
